Thursday, January 21, 2021

New trial finds arthritis drug no better than standard care for severe COVID-19

Adding the arthritis drug tocilizumab to standard care for patients in hospital with severe or critical covid-19 is no better than standard care alone in improving clinical outcomes at 15 days, according to results of a new trial.

from Top Health News -- ScienceDaily https://ift.tt/2YfvruZ

No comments:

Post a Comment

Unraveling the power and influence of language

A choice was made to include each word in this sentence. Every message, even the most mundane, is crafted with a specific frame in mind that...